PI
EBS icon

Putnam Investments’s Emergent Biosolutions EBS Stock Holding History

Putnam Investments’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-44,379
Closed -$4.12M – 805
2021
Q1 		$4.12M Sell
44,379
-73,142
-62% -$7.49M 0.01% 540
2020
Q4 		$10.5M Sell
117,521
-10,691
-8% -$981K 0.02% 361
2020
Q3 		$13.2M Sell
128,212
-5,929
-4% -$639K 0.03% 291
2020
Q2 		$10.6M Sell
134,141
-7,558
-5% -$563K 0.02% 316
2020
Q1 		$8.2M Sell
141,699
-620
-0.4% -$35.7K 0.02% 351
2019
Q4 		$7.68M Hold
142,319
– – 0.02% 428
2019
Q3 		$7.44M Sell
142,319
-4,994
-3% -$233K 0.02% 424
2019
Q2 		$7.12M Hold
147,313
– – 0.02% 440
2019
Q1 		$7.44M Buy
147,313
+132
+0.1% +$7.79K 0.02% 406
2018
Q4 		$8.72M Buy
147,181
+71
+0% +$4.58K 0.02% 348
2018
Q3 		$9.68M Buy
147,110
+89,907
+157% +$5.25M 0.02% 397
2018
Q2 		$2.89M Buy
57,203
+15,949
+39% +$831K 0.01% 642
2018
Q1 		$2.17M Hold
41,254
– – 0.01% 699
2017
Q4 		$1.92M Sell
41,254
-353
-0.8% -$14.9K ﹤0.01% 760
2017
Q3 		$1.68M Buy
+41,607
New +$1.51M ﹤0.01% 810
2017
Q2 		– Sell
-188,367
Closed -$5.47M – 1160
2017
Q1 		$5.47M Sell
188,367
-14,714
-7% -$448K 0.01% 556
2016
Q4 		$6.67M Buy
203,081
+24,033
+13% +$721K 0.02% 490
2016
Q3 		$5.65M Sell
179,048
-22,442
-11% -$652K 0.01% 533
2016
Q2 		$5.67M Sell
201,490
-181,266
-47% -$7.11M 0.01% 573
2016
Q1 		$13.9M Sell
382,756
-4,852
-1% -$171K 0.03% 373
2015
Q4 		$15.5M Sell
387,608
-81,393
-17% -$2.84M 0.04% 351
2015
Q3 		$13.4M Buy
469,001
+128
+0% +$4.22K 0.03% 382
2015
Q2 		$15.4M Sell
468,873
-124,214
-21% -$3.85M 0.03% 378
2015
Q1 		$17.1M Buy
593,087
+67,858
+13% +$1.95M 0.03% 378
2014
Q4 		$14.3M Sell
525,229
-4,670
-0.9% -$111K 0.03% 408
2014
Q3 		$11.3M Sell
529,899
-4,585
-0.9% -$105K 0.02% 450
2014
Q2 		$12M Buy
534,484
+351,084
+191% +$8.18M 0.03% 436
2014
Q1 		$4.63M Buy
+183,400
New +$4.63M 0.01% 787

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Putnam Investments's EBS Position: Q2 2021 in Review

Putnam Investments sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 44,379 shares — an estimated $4.12M sold.

Putnam Investments first reported a position in EBS in Q1 2014 and held it in 28 quarters. The position peaked at $17.1M in Q1 2015. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

  • Putnam Investments reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
  • Putnam Investments sold 44,379 Emergent Biosolutions shares in Q2 2021, an estimated $4.12M.
  • Putnam Investments first reported a position in Emergent Biosolutions in Q1 2014 and held it in 28 quarters.
  • Putnam Investments's Emergent Biosolutions position peaked at $17.1M in Q1 2015.
  • 290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Putnam Investments's 13F filing for Q2 2021, filed 16 Aug 2021.